Home » Topics » BioWorld Science, Immune

BioWorld Science, Immune
RSS

Headless hemagglutinin makes for broad-spectrum flu vaccine

March 23, 2021

Response to tabelecleucel leads to long-term survival in patients with EBV+ PTLD following HCT

March 22, 2021

China's NMPA approves emergency use of recombinant protein subunit vaccine against COVID-19

March 19, 2021

Ventyx initiates dosing in phase I study of VTX-958 for autoimmune diseases

March 18, 2021

Selexis and Pandion to advance development of PT-627

March 18, 2021

Anelixis begins phase II study of immunomodulation with AT-1501 in islet cell transplant

March 18, 2021

MaaT reports phase II topline data on MaaT-013 in steroid-refractory GI acute GvHD

March 17, 2021

First-in-human results presented for R-552 in healthy adults

March 17, 2021

Phase Ib/II data presented for itolizumab in patients with severe aGvHD

March 16, 2021

MaaT-013 shows safety and efficacy in patients with intestinal acute GvHD

March 16, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 17, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...